Sharon Bio-Medicine Ltd Annually Results

Gross Sales

253.45

838.46

1,324.79

1,073.52

804.14

Excise Duty

0

0

0

0

0

Net Sales

253.45

838.46

1,324.79

1,073.52

804.14

Other Operating Income

0

0

0

0

0

Other Income

1.95

2.63

1.92

1.19

1.24

Total Income

255.4

841.1

1,326.72

1,074.7

805.38

Total Expenditure

459.71

957.43

1,172.77

952.47

708.03

PBIDT

-204.3

-116.33

153.94

122.22

97.33

Interest

70.98

93.65

53.13

43.06

34.25

PBDT

-275.29

-209.98

100.8

79.16

63.06

Depreciation

15.01

19.26

15.35

12.13

8.85

Minority Interest Before NP

0

0

0

0

0

Tax

9.97

4.66

15.14

13.32

9.1

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-300.27

-233.9

70.31

53.7

45.11

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-300.27

-233.9

70.31

53.7

45.11

Extra-ordinary Items

-68.54

-82.91

-4.51

0

-0.02

Adjusted Profit After Extra-ordinary item

-231.73

-150.99

74.83

53.7

45.14

EPS (Unit Curr.)

-25.25

-19.67

6.65

50.86

40.95

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

18

15

0

Equity

23.79

23.79

21.11

10.56

10.56

Public Shareholding (Number)

0

0

4,20,17,020

41,94,125

41,44,325

Public Shareholding (%)

0

0

39.79

39.72

39.25

Pledged/Encumbered - No. of Shares

0

0

50,00,000

3,27,500

10,71,775

Pledged/Encumbered - % in Total Promoters Holding

0

0

7.94

5.15

16.7

Pledged/Encumbered - % in Total Equity

0

0

4.73

3.09

10.14

Non Encumbered - No. of Shares

0

0

5,85,51,980

60,35,275

53,40,800

Non Encumbered - % in Total Promoters Holding

0

0

92.12

94.84

83.29

Non Encumbered - % in Total Equity

0

0

55.45

57.16

50.59

PBIDTM(%)

-80.6

-13.87

11.62

11.38

12.1

PBDTM(%)

-108.61

-25.04

7.6

7.37

7.84

PATM(%)

-118.47

-27.89

5.3

5

5.6